Naloxone Injectable
This is an FDA approved injectable of naloxone hydrochloride to counteract the effects of an opioid overdose. This is designed to be used only by people with medical training. Can be administered intravenous, intramuscular, or subcutaneous. Available as a pack containing 10 single dose 1mL vials, a pack of 25 multi-dose 10mL vials, or a carton of 10 single dose 1mL ampules.
Availability: Commercially Available
+1 212 733 2323
235 East 42nd Street
NY, NY 10017
|
+1 800 879 3477
|
www.pfizer.com
Manufacturer |
| Hospira Inc |
Product Name |
| Naloxone Injectable |
Detection Category |
| Chemical |
Detection Method |
| Medical Countermeasure |
Application |
| Personal Protective Equipment; |
Product Model Number |
| NDC:0409-1215-25, 0409-1219-25, 0409-1215-01, 0409-1219-01, 0409-1212-01 |
Equipment Type |
| PPE |
Product Synopsis |
| This is an FDA approved injectable of naloxone hydrochloride to counteract the effects of an opioid overdose. This is designed to be used only by people with medical training. Can be administered intravenous, intramuscular, or subcutaneous. Available as a pack containing 10 single dose 1mL vials, a pack of 25 multi-dose 10mL vials, or a carton of 10 single dose 1mL ampules. |
Availability |
| Commercially Available |
Technology Readiness Level (TRL) |
| 9 |
User Feedback Sources |
| Indifferent/No user feedback |
No Information Is Available |
Transportability |
| Pocket Size |
Operating Conditions |
| Store at 20° to 25°C (68° to 77°F). Protect from light. |
Consumables |
| <$1,000/year; Syringes, Luer Lock needles |
Shelf Life |
| <5 years; 12-18 months |
Material |
| 0.4mg/mL naloxone hydrochloride |
Training Required |
| <1 hour training |